EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Early Detection of Hearing Impairment Signals Post-mRNA COVID-19 Vaccination: A Disproportionality Analysis Study on French Pharmacovigilance Database

Dalil Boulefaa iD, Haleh Bagheri, Francesco Salvo, Marie-Blanche Rabier, Hélène Geniaux, Marion Lepelley, Fanny Rocher, Julien Mahe, Aurélie Grandvillemuin, Hung Thai-Van

Drug Safety · 2025

DOI: 10.1007/s40264-024-01495-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Safety, 2025. Verfasst von Dalil Boulefaa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Clinical Pharmacology, Regional Pharmacovigilance Centre of Toulouse, Clinical Investigation Centre 1436, Toulouse Universi…. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19, Hearing Loss, Sensorineural. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Université Toulouse III - Paul Sabatier.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesCOVID-19Hearing Loss, SensorineuralHumansFrancePharmacovigilanceMaleFemaleMiddle AgedDatabases, FactualAdultAgedAdverse Drug Reaction Reporting SystemsEarly DiagnosisYoung AdultVaccinationAdolescentImmunization, Secondary

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Medical and Clinical Pharmacology, Regional Pharmacovigilance Centre of Toulouse, Clinical Investigation Centre 1436, Toulouse University Hospital, Toulouse, France. dalilboulefaa@gmail.com.
  • Department of Medical and Clinical Pharmacology, Regional Pharmacovigilance Centre of Toulouse, Clinical Investigation Centre 1436, Toulouse University Hospital, Toulouse, France.
  • Department of Medical Pharmacology, Hospital University of Bordeaux, Inserm, BPH, U1219, Equipe AHeaD, Bordeaux, France.
  • Regional Pharmacovigilance Centre of Franche-Comté, Besançon University Hospital, Besançon, France.
  • Regional Centre of Pharmacovigilance of Limoges, Limoges University Hospital, Limoges, France.
  • Regional Centre of Pharmacovigilance of Grenoble, Grenoble-Alpes University Hospital, Grenoble, France.

ORCID-Profile: Dalil Boulefaa

Förderung

  • Université Toulouse III - Paul Sabatier

Zitieren

APA

Boulefaa, D., Bagheri, H., Salvo, F., Rabier, M. B., Geniaux, H., Lepelley, M., Rocher, F., Mahe, J., Grandvillemuin, A., & Thai-Van, H. (2025). Early Detection of Hearing Impairment Signals Post-mRNA COVID-19 Vaccination: A Disproportionality Analysis Study on French Pharmacovigilance Database. Drug Safety. https://doi.org/10.1007/s40264-024-01495-5

Vancouver

Boulefaa D, Bagheri H, Salvo F, Rabier MB, Geniaux H, Lepelley M, et al. Early Detection of Hearing Impairment Signals Post-mRNA COVID-19 Vaccination: A Disproportionality Analysis Study on French Pharmacovigilance Database. Drug Safety. 2025. doi:10.1007/s40264-024-01495-5

BibTeX
@article{Boulefaa2025,
  author = {Boulefaa, Dalil and Bagheri, Haleh and Salvo, Francesco and Rabier, Marie-Blanche and Geniaux, Hélène and Lepelley, Marion and Rocher, Fanny and Mahe, Julien and Grandvillemuin, Aurélie and Thai-Van, Hung},
  title = {Early Detection of Hearing Impairment Signals Post-mRNA COVID-19 Vaccination: A Disproportionality Analysis Study on French Pharmacovigilance Database},
  journal = {Drug Safety},
  year = {2025},
  doi = {10.1007/s40264-024-01495-5}
}
Kostenlos starten →